Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Hendrix

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 17, 2024
Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibitionMelissa Schepers, Sven Hendrix, Femke Mussen, et al.
Neurobiology of Disease|October 1, 2013
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4Sofie Nelissen, Tim Vangansewinkel, Nathalie Geurts, et al.
Neurobiology of Disease|November 24, 2012
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expressionPawel Namsolleck, Francesco Boato, Katja Schwengel, et al.
Journal of Neuroinflammation|July 29, 2020
CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammationElien Grajchen, Elien Wouters, Britt van de Haterd, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2018
Mast cells as protectors of healthAnne Dudeck, Martin Köberle, Oliver Goldmann, et al.
Journal of Neuroinflammation|November 11, 2016
Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse modelDebbie Le Blon, Caroline Guglielmetti, Chloé Hoornaert, et al.
The Journal of Clinical Investigation|May 5, 2015
MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4James T Walsh, Sven Hendrix, Francesco Boato, et al.
Stem Cells (Dayton, Ohio)|March 19, 2016
In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell ImplantsChloé J Hoornaert, Evi Luyckx, Kristien Reekmans, et al.
Glia|September 30, 2016
Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophagesCaroline Guglielmetti, Debbie Le Blon, Eva Santermans, et al.
The Journal of Clinical Investigation|January 22, 2015
MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4James T Walsh, Sven Hendrix, Francesco Boato, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 17, 2024
Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibitionMelissa Schepers, Sven Hendrix, Femke Mussen, et al.
Neurobiology of Disease|October 1, 2013
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4Sofie Nelissen, Tim Vangansewinkel, Nathalie Geurts, et al.
Neurobiology of Disease|November 24, 2012
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expressionPawel Namsolleck, Francesco Boato, Katja Schwengel, et al.
Journal of Neuroinflammation|July 29, 2020
CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammationElien Grajchen, Elien Wouters, Britt van de Haterd, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2018
Mast cells as protectors of healthAnne Dudeck, Martin Köberle, Oliver Goldmann, et al.
Journal of Neuroinflammation|November 11, 2016
Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse modelDebbie Le Blon, Caroline Guglielmetti, Chloé Hoornaert, et al.
The Journal of Clinical Investigation|May 5, 2015
MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4James T Walsh, Sven Hendrix, Francesco Boato, et al.
Stem Cells (Dayton, Ohio)|March 19, 2016
In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell ImplantsChloé J Hoornaert, Evi Luyckx, Kristien Reekmans, et al.
Glia|September 30, 2016
Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophagesCaroline Guglielmetti, Debbie Le Blon, Eva Santermans, et al.
The Journal of Clinical Investigation|January 22, 2015
MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4James T Walsh, Sven Hendrix, Francesco Boato, et al.
Pageof 8